showed that FGL1 accumulated on the surface of breast cancer cells (28), this discrepancy can be attributed to that FGL1 may server as an oncogene in NSCLC in addition to its immune checkpoint role (44). This evidence concerns the gene FGL1 and non-small cell lung carcinoma.